CAN:s bibliotek

*000      am
*00113258
*008070120|2006|||||||||||e||||||||||0|eng|d
*020  $a0-8018-8219-2 (hardcover : alk. paper)$x0-8018-8219-2
*24514$aThe treatment of opioid dependence$wtreatment of opioid dependence
*260  $aBaltimore, Md :$bJohns Hopkins University Press,$c2006$y2006
*300  $axx, 551 s :$bill.
*520  $aIntroduction and historical overview. Regulatory, cost, and policy issues. Epidemiology of opioid use, abuse, and dependence. Pharmacology of methadone. Beginning and ending methadone dosing: induction and withdrawal. Methadone dose during maintenance treatment. Counseling and psychosocial services. Contingency management therapies. Practical issues of program organization and operation. Pharmacology of buprenorphine. Clinical use of buprenorphine. Office-based treatment with buprenorphine and other medications. Pharmacology and clinical use of LAAM, clonidine, and lofexidine. Pharmacology and clinical use of naltrexone. Medication-free treatment of opioid dependence. Medically supervised withdrawal as stand-alone treatment. Other substance use disorders in the treatment of opioid dependence: prevalence, consequences, detection, and management. Comorbid medical disorders. Comorbid psychiatric disorders. Specialty treatment for women. Treatment of persons under legal restrictions. Treatment of adolescents. Prescription opioid nonmedical use and abuse. Pain management in addicted patients. (From the table of contents)
*650 4$aOpioid-related disorders
*650 4$aMethadone
*650 4$aRehabilitation
*650 4$aBuprenorphine
*650 4$aClonidine
*650 4$aNaltrexone
*650 4$aComorbidity
*653  $aOpiatmissbruk
*653  $aRehabilitering
*653  $aMetadon
*653  $aBuprenorfin
*653  $aKlonidin
*653  $aNaltrexon
*653  $aBehandling
*653  $aLAAM
*7001 $aStrain, Eric C.$eed.
*7001 $aStitzer, Maxine L.$eed.
*852  $h5d133
^